| Bayer (Schweiz) AG - Jivi 250 IE, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung |
| 66882 | | 01 | | Jivi 250 IE | | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | | B02BD02 | | Coagulation Factor Viii | | 18.06.2019 | | |
|
| Composition |
| Praeparatio cryodesiccata: damoctocogum alfa pegolum 250 U.I., calcii chloridum dihydricum, glycinum, histidinum, natrii chloridum, saccharum, polysorbatum 80, acidum aceticum glaciale, pro vitro corresp. natrium 1.8 mg.
Solvens: aqua ad iniectabile 2.5 ml. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | Lyophilisate and solvent | | | | | | Active Agent | Dose |
|---|
| Damoctocogum alfa Pegolum | 250 UI |
| | | | Inactive agents |
|---|
| Acidum Aceticum Glaciale | | Calcium Chloride | | Glycin | | Histidine | | Sodium Chloride | | Polysorbatum 80 | | Saccharum |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
